Cannabinoids | Medical Cannabis

Canna~Fangled Abstracts

The changing landscape of the use of medical marijuana after traumatic brain injury: a narrative review

Brain Inj. 2021 Oct 10;1-11. doi: 10.1080/02699052.2021.1978548. Online ahead of print. Patrick A Saulino 1, Brian D…

Freedom WaresOctober 10, 2021

Canna~Fangled Abstracts

Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls

Eur J Pain. 2021 Oct 8. doi: 10.1002/ejp.1874. Online ahead of print. Carsten Hjorthøj 1 2, Peter La…

Freedom WaresOctober 9, 2021

Canna~Fangled Abstracts

Medical Cannabis for Headache Pain: a Primer for Clinicians

Review Curr Pain Headache Rep. 2021 Oct 9;25(10):64. doi: 10.1007/s11916-021-00974-z. Robert A Duarte 1 2, Stephen Dahmer 3 4, Shayna Y…

Freedom WaresOctober 9, 2021

Canna~Fangled Abstracts

In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells

Review Molecules. 2021 Oct 8;26(19):6077. doi: 10.3390/molecules26196077. Jungnam Kim 1, Hyunwoo Choi 1, Eunhye K Kang 1, Gil Yong Ji 2, Youjeong Kim 2, Insung…

Freedom WaresOctober 9, 2021

Canna~Fangled Abstracts

Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis

Mikrochim Acta. 2021 Oct 7;188(11):368. doi: 10.1007/s00604-021-05029-z. Alberto Gómez-Caballero 1, Ainhoa Elejaga-Jimeno 2, Gontzal García Del Caño 3, Nora Unceta 2, Antonio Guerreiro 4, Miquel…

Freedom WaresOctober 7, 2021

Canna~Fangled Abstracts

Calculated and Experimental 1 H and 13 C NMR Assignments for Cannabicitran

Magn Reson Chem. 2021 Oct 7. doi: 10.1002/mrc.5224. Online ahead of print. Jared S Wood 1, William…

Freedom WaresOctober 7, 2021

Canna~Fangled Abstracts

Protected: Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

This content is password protected. To view it please enter your password below: Password:

Freedom WaresOctober 7, 2021

Canna~Fangled Abstracts

The CB 1 Receptor Positive Allosteric Modulator, ZCZ011, Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice

J Pharmacol Exp Ther. 2021 Oct 8;JPET-AR-2021-000723. doi: 10.1124/jpet.121.000723. Online ahead of print. Julien C Dodu 1, Rebecca…

Freedom WaresOctober 7, 2021

The changing landscape of the use of medical marijuana after traumatic brain injury: a narrative review

Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls

Medical Cannabis for Headache Pain: a Primer for Clinicians

In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells

Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis

Calculated and Experimental 1 H and 13 C NMR Assignments for Cannabicitran

Protected: Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

The CB 1 Receptor Positive Allosteric Modulator, ZCZ011, Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice

Recent Posts

Archives

Categories